BARX2 and esophageal squamous cell carcinoma: A study by Chen et al. [13] on ESCC found that PHLDA3 and BarH-like homeobox 2 (BARX2), a downstream target of Wnt/β-catenin signaling, inhibit gastric cancer progression.